Expanding Horizons: Pioneering Healthcare Innovation
From humble beginnings as a contract manufacturer for industry leaders, this company has come a long way. Now, the company is strategically transitioning from a B2B model to a B2B2C approach, offering a diverse array of healthcare solutions. They are focusing on branded segments like Petcare, Nutrition, and Cosmetics. They have set ambitious targets, aiming for a robust 25-30% CAGR growth between FY24 to FY26, while maintaining a healthy EBITDA margin of 12-15%. Currently trading at a multiple of 25x FY24 earnings, the stock presents an enticing opportunity, considering its strong growth prospects.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed